Content Type: Research Publications

High Generic Drug Prices and Market Competition: A Retrospective Cohort Study

March 15, 2026

Effect of US Food and Drug Administration’s Cardiovascular Safety Guidance on Diabetes Drug Development

March 15, 2026

Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval By the US Food and Drug Administration

March 15, 2026

Influence, Integrity, and the FDA: An Ethical Framework

March 15, 2026

Safety Related Label Changes for New Drugs After Approval in the US Through Expedited Regulatory Pathways: Retrospective Cohort Study

March 15, 2026

Outcomes-Based Pharmaceutical Contracts: An Answer to High U.S. Drug Spending?

March 15, 2026

Six-Month Market Exclusivity Extensions to Promote Research Offer Substantial Returns for Many Drug Makers

March 15, 2026

The Real‐World Ethics of Adaptive‐design Clinical Trials

March 15, 2026

Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High‐risk Otolaryngologic Devices, 2000‐2014

March 15, 2026

Strategies That Delay Market Entry of Generic Drugs

March 15, 2026

Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence

March 15, 2026

Determinants of Market Exclusivity for Prescription Drugs in the United States

March 15, 2026